# Umbilical Cord Mesenchymal Stem Cells for Immune Reconstitution in HIV-infected Patients

> **NCT01213186** · PHASE2 · UNKNOWN · sponsor: **Fu-Sheng Wang** · enrollment: 72 (estimated)

## Conditions studied

- Human Immunodeficiency Virus
- Disorder of Immune Reconstitution

## Interventions

- **DRUG:** high dose of MSC
- **DRUG:** low dose of MSC treatment

## Key facts

- **NCT ID:** NCT01213186
- **Lead sponsor:** Fu-Sheng Wang
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-01
- **Primary completion:** 2015-12
- **Final completion:** 2016-06
- **Target enrollment:** 72 (ESTIMATED)
- **Last updated:** 2013-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01213186

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01213186, "Umbilical Cord Mesenchymal Stem Cells for Immune Reconstitution in HIV-infected Patients". Retrieved via MORVS 2026-10-10 from https://api.morvs.ai/clinical/NCT01213186. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*